Nanobiotix Sa ADR (NBTX) has released an update.
Nanobiotix Sa ADR, a pioneering biotech firm in late-stage clinical development, has disclosed its latest monthly voting rights and share capital information, indicating a total of 47,133,328 shares outstanding with 48,899,410 theoretical voting rights and 48,877,292 exercisable voting rights as of March 31, 2024. The company, which specializes in nanotechnology platforms for oncology and other applications, is committed to expanding treatment possibilities and holds over 20 umbrella patents.
For further insights into NBTX stock, check out TipRanks’ Stock Analysis page.
